Skip to content
Clinical Trials – home

Somogy Varmegyei Kaposi Mor Oktato Korhaz

Research site

Hungary Tallian Gyula Utca 20-32, 7400 Kaposvar, Hungary

  • 28 trials recruiting
  • Psoriasis · Chronic lymphocytic leukaemia · Dermatitis atopic
  • Adults and children

About Specializations

Somogy Varmegyei Kaposi Mor Oktato Korhaz in Kaposvar, Hungary specialises in clinical trials of conditions such as Psoriasis, Chronic lymphocytic leukaemia, Dermatitis atopic, Non-small cell lung cancer, and other specialisations. This site conducts important research.

Main research areas of the site

Oncology

The medical center is at the forefront of oncology research, focusing on innovative treatments for various cancer types. The center's work in metastatic colorectal cancer and triple-negative breast cancer is particularly noteworthy, as it explores novel therapeutic combinations to improve patient outcomes.

  • Microsatellite Instability-High (MSI-H) Colorectal Cancer
  • Triple-Negative Breast Cancer (TNBC)
  • Small Cell Lung Cancer (SCLC)

Through rigorous clinical trials, the center is advancing the understanding of cancer biology and treatment efficacy, contributing significantly to the global fight against cancer.

Dermatology

Specializing in dermatology, the center conducts cutting-edge research on skin conditions such as atopic dermatitis and plaque psoriasis. By evaluating new treatment modalities, the center aims to enhance the quality of life for patients suffering from these chronic conditions.

  • Atopic Dermatitis
  • Plaque Psoriasis

The center's research efforts are pivotal in developing therapies that target the underlying mechanisms of skin diseases, offering hope for more effective management strategies.

Gastroenterology

In the field of gastroenterology, the center is renowned for its research on conditions like ulcerative colitis and hepatic encephalopathy. By investigating new pharmacological interventions, the center seeks to improve therapeutic outcomes and patient care.

  • Ulcerative Colitis
  • Hepatic Encephalopathy

The center's commitment to gastroenterological research is evident in its pursuit of innovative solutions that address both the symptoms and causes of these complex diseases.

Cardiology

The center's cardiology research focuses on advancing treatments for atrial fibrillation and related cardiovascular conditions. By exploring novel anticoagulant therapies, the center aims to reduce the risk of stroke and improve patient safety.

  • Atrial Fibrillation

Through its research, the center is contributing to the development of safer and more effective cardiovascular treatments, enhancing patient outcomes and quality of life.

Nephrology

In nephrology, the center is dedicated to understanding and treating kidney-related conditions such as IgA nephropathy and chronic kidney disease-associated pruritus. The center's research is focused on innovative therapies that aim to improve renal function and patient comfort.

  • IgA Nephropathy
  • Chronic Kidney Disease-associated Pruritus

The center's work in nephrology is crucial in developing treatments that address both the physiological and symptomatic aspects of kidney diseases.

Women's Health

The center is a leader in women's health research, particularly in the areas of endometriosis and breast cancer. By evaluating new treatment options, the center aims to alleviate symptoms and improve the quality of life for women affected by these conditions.

  • Endometriosis
  • Breast Cancer

Through its research, the center is making significant strides in understanding and treating conditions that predominantly affect women, contributing to better health outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Tallian Gyula Utca 20-327400 KaposvarHungary
Recruiting now
28 trials
Conditions studied
96

More sites in KaposvarHungary

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

123 clinical trials

Study of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years
  • Substances:Bevacizumab
  • Sponsor:Amgen Inc.

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Tozorakimab
  • Sponsor:AstraZeneca AB

Study of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Dostarlimab
  • Sponsor:Glaxosmithkline Research & Development Limited

Study on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Favezelimab
  • Sponsor:Merck Sharp & Dohme LLC

Zenagamtide versus semaglutide: a study of blood sugar and weight reduction in adults with type 2 diabetes inadequately controlled on metformin and/or SGLT2 inhibitor

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

Phase III trial evaluating ianalumab with background drug combination in patients with Sjögren's disease

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Emtricitabine
  • Sponsor:Novartis Pharma AG

Study of AZD0486 plus rituximab versus standard chemotherapy drug combination in previously untreated follicular lymphoma patients

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:AstraZeneca AB

VMX-C001 in Patients Taking Factor Xa Inhibitors Who Need Urgent Surgery or an Invasive Procedure With High Bleeding Risk

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:VMX-C001
  • Sponsor:VarmX B.V.

A Study of Zenagamtide in Adults With Overweight or Obesity and Type 2 Diabetes

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:POLYPEPTIDE CONSISTING OF A GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST AND AN AMYLIN RECEPTOR AGONIST, CONNECTED BY A LINKER WITH 4 GLYCINE RESIDUES, AND CONNECTED TO A C18 FATTY ACID SIDE CHAIN
  • Sponsor:Novo Nordisk A/S

A study of PF-08634404 and a drug combination in adults with advanced or metastatic non-small cell lung cancer

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Pfizer Inc.

Study of ziftomenib with drug combinations for adults with newly diagnosed acute myeloid leukemia with NPM1 or KMT2A genetic changes

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Kura Oncology Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.